Down-regulation of liver JAK2-STAT5b signaling by the female plasma pattern of continuous growth hormone stimulation

Mol Endocrinol. 1999 Feb;13(2):213-27. doi: 10.1210/mend.13.2.0238.

Abstract

The suppression of male-specific, GH pulse-induced, liver transcription in adult female rats has been linked to the down-regulation of STAT5b activation by the female plasma pattern of near-continuous GH exposure. The mechanism underlying this down-regulation was studied in the rat liver cell line CWSV-1, where continuous GH suppressed the level of activated (tyrosine- phosphorylated) STAT5b to approximately 10-20% of the maximal GH pulse-induced STAT5b signal within 3 h. In contrast to the robust JAK2 kinase-dependent STAT5b activation loop that is established by a GH pulse, JAK2 kinase signaling to individual STAT5b molecules was found to be short lived in cells treated with GH continuously. Moreover, maintenance of the low-level STAT5b signal required ongoing protein synthesis and persisted for at least 7 days provided that GH was present in the culture continuously. Increased STAT5b DNA-binding activity was observed in cells treated with the proteasome inhibitor MG132, suggesting that at least one component of the GH receptor (GHR)-JAK2-STAT5b signaling pathway becomes labile in response to continuous GH treatment. The phosphotyrosine phosphatase inhibitor pervanadate fully reversed the down-regulation of STAT5b DNA-binding activity in continuous GH-treated cells by a mechanism that involves both increased STAT5b activation and decreased STAT5b dephosphorylation. Moreover, the requirement for ongoing GH stimulation and active protein synthesis to maintain STAT5b activity in continuous GH-treated cells were both eliminated by pervanadate treatment, suggesting that phosphotyrosine dephosphorylation may be an obligatory first step in the internalization/degradation pathway for the GHR-JAK2 complex. Finally, the sustaining effect of the serine kinase inhibitor H7 on GH pulse-induced JAK2 signaling to STAT5b was not observed in continuous GH-treated cells. These findings suggest a model where continuous GH exposure of liver cells down-regulates the STAT5b pathway by a mechanism that involves enhanced dephosphorylation of both STAT5b and GHR-JAK2, with the latter step leading to increased internalization/degradation of the re-ceptor-kinase complex.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / metabolism
  • Animals
  • Cells, Cultured
  • Cycloheximide / metabolism
  • Cysteine Proteinase Inhibitors / metabolism
  • DNA-Binding Proteins / physiology*
  • Down-Regulation
  • Electrophoresis
  • Female
  • Genistein / metabolism
  • Growth Hormone / physiology*
  • Growth Inhibitors / metabolism
  • Janus Kinase 2
  • Leupeptins / metabolism
  • Liver / physiology
  • Male
  • Milk Proteins*
  • Protein Synthesis Inhibitors / metabolism
  • Protein Tyrosine Phosphatases / antagonists & inhibitors
  • Protein-Tyrosine Kinases / physiology*
  • Proto-Oncogene Proteins*
  • Rats
  • STAT5 Transcription Factor
  • Signal Transduction / physiology*
  • Staurosporine / metabolism
  • Trans-Activators / physiology*
  • Vanadates / metabolism

Substances

  • Cysteine Proteinase Inhibitors
  • DNA-Binding Proteins
  • Growth Inhibitors
  • Leupeptins
  • Milk Proteins
  • Protein Synthesis Inhibitors
  • Proto-Oncogene Proteins
  • STAT5 Transcription Factor
  • Stat5b protein, rat
  • Trans-Activators
  • pervanadate
  • Vanadates
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • Growth Hormone
  • Cycloheximide
  • Genistein
  • Protein-Tyrosine Kinases
  • Jak2 protein, rat
  • Janus Kinase 2
  • Protein Tyrosine Phosphatases
  • Staurosporine
  • benzyloxycarbonylleucyl-leucyl-leucine aldehyde